Pathology/Immunology Core
病理学/免疫学核心
基本信息
- 批准号:7681501
- 负责人:
- 金额:$ 15.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-01 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAlgorithmsAlkaline PhosphataseAnimal ModelAntibodiesAntigensApoptosisAreaAutoantibodiesAutopsyBiological AssayCanis familiarisCell CycleCellsClinicalDerivation procedureDetectionDevelopmentDiabetes MellitusDirect immunofluorescenceDiseaseDoseDuct (organ) structureElementsEndocrineEnvironmentEvaluationEyeFixativesFloridaFreezingFrozen SectionsFunctional disorderGenetic Predisposition to DiseaseGlucagonGlutamate DecarboxylaseGoalsHistocytochemistryHistologyHistopathologyHumanHuman ResourcesIA-2-autoantibodyImmune responseImmune systemImmunofluorescence ImmunologicImmunohistochemistryImmunologicsImmunologyIn Situ HybridizationInflammationInflammatoryInsulinInsulin-Dependent Diabetes MellitusInterventionInvestigationKidneyLabelLaboratoriesLymphoidMeasuresMessenger RNAMethodsModelingMolecularMorphologyMusOrganPancreasPancreatic PolypeptideParaffinParaffin EmbeddingPathogenesisPathologyPatientsPerformancePeroxidasePeroxidasesPrevention strategyPrimatesPrincipal InvestigatorProceduresProcessRattusReagentResearchResearch PersonnelRiskRisk AssessmentSafetySamplingSerumSiteSomatostatinSpleenStagingStaining methodStainsStandardizationStandards of Weights and MeasuresTechniquesTestingTherapeuticTissue MicroarrayTissuesTrainingUniversitiescytotoxicitydisorder preventionexperienceghrelinhuman subjectimprovedinterestlymph nodesmolecular pathologypolyclonal antibodypreclinical studypreventprogramsresponsesample fixationtreatment durationtreatment effect
项目摘要
The Molecular Pathology and Immunology Core of the University of Florida currently assists multiple
investigators participating in Projects aimed at an improved understanding of the pathogenesis of type 1
diabetes, as well as the development of agents capable of reversing and/or preventing the disease.
Specifically, the Core supports these investigations by performing pathological and immunological analyses
that characterize the host's immune system and cell/tissue response, including those involving treatments
proposed or currently used in experimental and preclinical studies. This goal has and will continue to be
accomplished by performance of three specific aims: 1) Determine tissue morphology in the context of
histopathology in order to evaluate treatment effects with respect to administration site, dose, and treatment
duration. 2) Determine the potential beneficial effects of treatments in murine models of diabetes; with
assessment of the pancreas as well other organs related to type 1 diabetes. 3) Perform immunologic
evaluations in animal models and human subjects that characterize aspects related to the humoral and
cellular immune response, as well as providing genetic susceptibility to type 1 diabetes. The morphological
studies are vital in order to evaluate whether a given Project's intervention successfully ameliorates the pro-
inflammatory environment within the pancreas, lymph node, spleen, and other organs and to determine the
extent to which any intervention induces acute inflammation or cytotoxicity. Centralization of the
morphological studies, and standardization of the histopathological and toxicological determinants, enables
rigorous assessment of cellular responses. Procedures include standard histology on paraffin and frozen
materials, special stains, histochemistry, immunohistochemistry, and immunofluorescence. In terms of
analysis of human samples, the Core laboratory will build upon more that two decades of experience in
terms of evaluating for the presence of autoantibodies in serum of patients with or at increased-risk of type 1
diabetes, as well as determining the genetic susceptibility for the disease by performance of HLA typing. In
addition to providing a critical element for assurance of therapeutic safety and improved mechanistic
understanding, the Core should provide information that will enhance the feasibility and efficacy of preclinical
trials to prevent or reverse type 1 diabetes.
佛罗里达大学分子病理学和免疫学核心目前协助
参与旨在提高对1型肺炎发病机制理解的项目的研究人员
糖尿病,以及能够逆转和/或预防这种疾病的药物的开发。
具体地说,核心通过进行病理和免疫学分析来支持这些调查
宿主的免疫系统和细胞/组织反应的特征,包括涉及治疗的那些
建议的或目前用于实验和临床前研究的。这一目标过去是,也将继续是
通过实现以下三个具体目标来实现:1)在以下情况下确定组织形态
组织病理学,以评估治疗效果的给药部位,剂量和治疗
持续时间。2)确定治疗糖尿病小鼠模型的潜在有益效果;
评估胰腺和其他与1型糖尿病相关的器官。3)进行免疫学
在动物模型和人类受试者中的评价,表征与体液和
细胞免疫反应,以及提供1型糖尿病的遗传易感性。形态上的
研究对于评估特定项目的干预是否成功地改善亲和力至关重要。
胰腺、淋巴结、脾和其他器官内的炎症环境,并确定
任何干预措施引起急性炎症或细胞毒性的程度。集中管理
形态研究和组织病理学和毒理学决定因素的标准化,使
对细胞反应的严格评估。程序包括石蜡和冰冻切片的标准组织学
材料、特殊染色、组织化学、免疫组织化学和免疫荧光。就.而言
对于人体样本的分析,核心实验室将建立在20多年的经验基础上
1型高危或高危患者血清中自身抗体存在的评估术语
糖尿病,以及通过表现的人类白细胞抗原配型来确定疾病的遗传易感性。在……里面
除了为确保治疗安全性和改进机制提供关键要素之外
理解,核心应提供信息,以加强临床前治疗的可行性和有效性
预防或逆转1型糖尿病的试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARTHA CAMPBELL-THOMPSON其他文献
MARTHA CAMPBELL-THOMPSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARTHA CAMPBELL-THOMPSON', 18)}}的其他基金
Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes
了解 1 型糖尿病前期的胰腺内分泌和外分泌丧失
- 批准号:
10461979 - 财政年份:2020
- 资助金额:
$ 15.37万 - 项目类别:
Multi-omic 3D tissue maps for a Human BioMolecular Atlas
人类生物分子图谱的多组学 3D 组织图谱
- 批准号:
10685583 - 财政年份:2020
- 资助金额:
$ 15.37万 - 项目类别:
Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes
了解 1 型糖尿病前期的胰腺内分泌和外分泌丧失
- 批准号:
10226911 - 财政年份:2020
- 资助金额:
$ 15.37万 - 项目类别:
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes
1 型糖尿病早期 β 细胞功能障碍的途径和关键调节因子
- 批准号:
10202585 - 财政年份:2019
- 资助金额:
$ 15.37万 - 项目类别:
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes
1 型糖尿病早期 β 细胞功能障碍的途径和关键调节因子
- 批准号:
10441263 - 财政年份:2019
- 资助金额:
$ 15.37万 - 项目类别:
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes
1 型糖尿病早期 β 细胞功能障碍的途径和关键调节因子
- 批准号:
9802936 - 财政年份:2019
- 资助金额:
$ 15.37万 - 项目类别:
Neuromodulation-based treatment of diabetes: identifying anatomical and physiological pancreatic innervation targets
基于神经调节的糖尿病治疗:确定解剖学和生理学胰腺神经支配目标
- 批准号:
9752693 - 财政年份:2016
- 资助金额:
$ 15.37万 - 项目类别:
Defining Islet Heterogeneity Using Single Islet Transcriptomics
使用单胰岛转录组学定义胰岛异质性
- 批准号:
8812982 - 财政年份:2014
- 资助金额:
$ 15.37万 - 项目类别:
Pancreas Volume in Preclinical Type 1 Diabetes
临床前 1 型糖尿病的胰腺体积
- 批准号:
8644494 - 财政年份:2013
- 资助金额:
$ 15.37万 - 项目类别:
Leica Laser Microdissection Microscope for a Shared Resource
共享资源的徕卡激光显微切割显微镜
- 批准号:
8448032 - 财政年份:2013
- 资助金额:
$ 15.37万 - 项目类别:
相似海外基金
DMS-EPSRC: Asymptotic Analysis of Online Training Algorithms in Machine Learning: Recurrent, Graphical, and Deep Neural Networks
DMS-EPSRC:机器学习中在线训练算法的渐近分析:循环、图形和深度神经网络
- 批准号:
EP/Y029089/1 - 财政年份:2024
- 资助金额:
$ 15.37万 - 项目类别:
Research Grant
CAREER: Blessing of Nonconvexity in Machine Learning - Landscape Analysis and Efficient Algorithms
职业:机器学习中非凸性的祝福 - 景观分析和高效算法
- 批准号:
2337776 - 财政年份:2024
- 资助金额:
$ 15.37万 - 项目类别:
Continuing Grant
CAREER: From Dynamic Algorithms to Fast Optimization and Back
职业:从动态算法到快速优化并返回
- 批准号:
2338816 - 财政年份:2024
- 资助金额:
$ 15.37万 - 项目类别:
Continuing Grant
CAREER: Structured Minimax Optimization: Theory, Algorithms, and Applications in Robust Learning
职业:结构化极小极大优化:稳健学习中的理论、算法和应用
- 批准号:
2338846 - 财政年份:2024
- 资助金额:
$ 15.37万 - 项目类别:
Continuing Grant
CRII: SaTC: Reliable Hardware Architectures Against Side-Channel Attacks for Post-Quantum Cryptographic Algorithms
CRII:SaTC:针对后量子密码算法的侧通道攻击的可靠硬件架构
- 批准号:
2348261 - 财政年份:2024
- 资助金额:
$ 15.37万 - 项目类别:
Standard Grant
CRII: AF: The Impact of Knowledge on the Performance of Distributed Algorithms
CRII:AF:知识对分布式算法性能的影响
- 批准号:
2348346 - 财政年份:2024
- 资助金额:
$ 15.37万 - 项目类别:
Standard Grant
CRII: CSR: From Bloom Filters to Noise Reduction Streaming Algorithms
CRII:CSR:从布隆过滤器到降噪流算法
- 批准号:
2348457 - 财政年份:2024
- 资助金额:
$ 15.37万 - 项目类别:
Standard Grant
EAGER: Search-Accelerated Markov Chain Monte Carlo Algorithms for Bayesian Neural Networks and Trillion-Dimensional Problems
EAGER:贝叶斯神经网络和万亿维问题的搜索加速马尔可夫链蒙特卡罗算法
- 批准号:
2404989 - 财政年份:2024
- 资助金额:
$ 15.37万 - 项目类别:
Standard Grant
CAREER: Efficient Algorithms for Modern Computer Architecture
职业:现代计算机架构的高效算法
- 批准号:
2339310 - 财政年份:2024
- 资助金额:
$ 15.37万 - 项目类别:
Continuing Grant
CAREER: Improving Real-world Performance of AI Biosignal Algorithms
职业:提高人工智能生物信号算法的实际性能
- 批准号:
2339669 - 财政年份:2024
- 资助金额:
$ 15.37万 - 项目类别:
Continuing Grant